The high percentage of Lin-/HLA-DR+ DCs expressing CD83 observed in breast cancer patients could be induced by tumour-derived factors, as suggested by the observation that the increased expression of CD83 by PB DCs was completely reverted in our patients 4 weeks after surgical removal of the tumour. This evidence concerns the gene CD83 and neoplasm.